Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,518 | $33,565 | $5,013,643 | $13,372,541 |
| - Cash | $298,036 | $774,396 | $1,879,431 | $2,955,212 |
| + Debt | $369,089 | $826,186 | $899,643 | $70,775 |
| Enterprise Value | $105,571 | $85,355 | $4,033,855 | $10,488,104 |
| Revenue | $470,833 | $491,373 | $406,461 | $415,862 |
| % Growth | -4.2% | 20.9% | -2.3% | – |
| Gross Profit | $367,746 | $389,205 | $313,998 | $324,344 |
| % Margin | 78.1% | 79.2% | 77.3% | 78% |
| EBITDA | -$612,957 | -$547,837 | -$999,369 | -$324,029 |
| % Margin | -130.2% | -111.5% | -245.9% | -77.9% |
| Net Income | -$714,307 | -$703,754 | -$1,057,699 | -$373,636 |
| % Margin | -151.7% | -143.2% | -260.2% | -89.8% |
| EPS Diluted | -1.63 | -1.61 | -2.42 | -0.85 |
| % Growth | -1.2% | 33.5% | -184.7% | – |
| Operating Cash Flow | $23,739 | -$610,019 | -$729,459 | -$456,917 |
| Capital Expenditures | -$41,556 | -$262,908 | -$178,774 | -$145,164 |
| Free Cash Flow | -$17,817 | -$872,927 | -$908,233 | -$602,081 |